BioSpace News Archive

On January 4, DMM.com Inc. announces its official founding of DMM Mining Labo, which manages research and development of cryptocurrency mining machines.

The new capital will be used to further develop and commercialize the PiCSO Impulse System.

Pixium Vision announced today that it has received the approval from the US Food and Drug Administration (FDA) to begin the clinical feasibility study for PRIMA, Pixium Vision’s new-generation miniaturized wireless photovoltaic sub-retinal implant, in patients with Atrophic Dry Age-related Macular Degeneration (AMD).

Nuevolution today announced that Janssen Biotech has exercised its option to license one of the research programs under the multi-target collaboration entered between the parties in October 2015 - a collaboration that was expanded further in April 2016 and March 2017.

Inflazome today announces the appointment of Prof. Paul Ridker to Inflazome’s Scientific Advisory Board.

Provincial coverage approvals are in process, initially focused on British Columbia and Ontario, and are expected to expand across Canada.

With more than 23 years engineering expertise and leadership experience, Hyde will manage the worldwide expansion of Pelican BioThermal’s Crēdo on Demand rental program.

Thermis announced today the close of a Series C financing round totaling EUR 10 million.

The randomized, double-blind, placebo-controlled multi-site Phase 3 trial, conducted in Europe, is evaluating the efficacy and safety of two dosing regimens - once daily or twice daily.

BioLife today announced preliminary Q4 and full year 2017 revenue and provided additional operational updates and financial guidance for 2018.